Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations
Gaelle Frénois-Veyrat, Franck Gallardo, Olivier Gorgé, Elie Marcheteau, Olivier Ferraris, Artem Baidaliuk, Anne‐Laure Favier, Cécile Enfroy, Xavier Holy, Jérémy Lourenco, Rhéa Khoury, Flora Nolent, Douglas W. Grosenbach, Dennis E. Hruby, Audrey Ferrier, Frédéric Iseni, Etienne Simon‐Lorière, Jean‐Nicolas Tournier
Topics & Concepts
MonkeypoxVirologyIn vitroOutbreakVirusCidofovirFood and drug administrationClinical trialBiologyMedicinePharmacologyRecombinant DNAVacciniaBioinformaticsGeneBiochemistryPoxvirus research and outbreaksHerpesvirus Infections and TreatmentsBacillus and Francisella bacterial research